Literature DB >> 21448783

Eight months of continuous positive airway pressure (CPAP) decrease tumor necrosis factor alpha (TNFA) in men with obstructive sleep apnea syndrome.

Andrea Hegglin1, Otto D Schoch, Wolfgang Korte, Kirsten Hahn, Christoph Hürny, Thomas Münzer.   

Abstract

OBJECTIVES: The aim of this study was to assess serum tumor necrosis factor alpha (TNFA) concentrations 8 months of continuous positive airway pressure (CPAP) therapy.
DESIGN: This study used prospective, observational clinical trial. PATIENTS: Sixty-six patients with newly diagnosed sleep apnea syndrome (12 women, 54 men), age 52.3 ± 9.8 (mean ± SD) with a body mass index of 29.7 ± 4.4 and an apnea-hypopnea index of 39.7 ± 26.8, were studied. INTERVENTION: CPAP was administered for a mean of 7.8 ± 1.3 months. MEASUREMENTS AND
RESULTS: TNFA concentrations using an ultrasensitive ELISA assay at baseline and follow-up. TNFA decreased in men with high (5.2 ± 1.7 h/night, -0.46 ± 1.1 ng/l, p = 0.001) and with low (2.5 ± 1.0 h/night -0.63 ± 0.77 ng/l, p = 0.001) adherence but not in women. Average number of hours of CPAP use correlated positively with delta TNFA (R (2) 0.08, p = 0.04)
CONCLUSION: Long-term CPAP positively affects TNFA even in men with poor adherence to CPAP.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448783     DOI: 10.1007/s11325-011-0512-2

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  32 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  C-reactive protein evolution in obstructive sleep apnoea patients under CPAP therapy.

Authors:  Sophia E Schiza; Charalampos Mermigkis; Panagou Panagiotis; Izolde Bouloukaki; Eleftherios Kallergis; Nikolaos Tzanakis; Eleni Tzortzaki; Eleni Vlachaki; Nikolaos M Siafakas
Journal:  Eur J Clin Invest       Date:  2010-08-19       Impact factor: 4.686

3.  Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.

Authors:  K Chin; K Shimizu; T Nakamura; N Narai; H Masuzaki; Y Ogawa; M Mishima; T Nakamura; K Nakao; M Ohi
Journal:  Circulation       Date:  1999-08-17       Impact factor: 29.690

4.  Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

Authors:  Silke Ryan; Cormac T Taylor; Walter T McNicholas
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

5.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

6.  German version of the Epworth Sleepiness Scale.

Authors:  K E Bloch; O D Schoch; J N Zhang; E W Russi
Journal:  Respiration       Date:  1999       Impact factor: 3.580

Review 7.  The role of cytokines in sleep regulation.

Authors:  James M Krueger
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 8.  Epidemiology of obstructive sleep apnea.

Authors:  E A Bresnitz; R Goldberg; R M Kosinski
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

9.  Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome.

Authors:  Zuzana Dorkova; Darina Petrasova; Angela Molcanyiova; Marcela Popovnakova; Ruzena Tkacova
Journal:  Chest       Date:  2008-07-14       Impact factor: 9.410

10.  The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea.

Authors:  Craig L Phillips; Qiao Yang; Andrew Williams; Michael Roth; Brendon J Yee; Jan A Hedner; Norbert Berend; Ronald R Grunstein
Journal:  J Sleep Res       Date:  2007-06       Impact factor: 3.981

View more
  6 in total

1.  Can gestational hypertension be modified by treating nocturnal airflow limitation?

Authors:  John Reid; Regina Taylor-Gjevre; John Gjevre; Robert Skomro; Mark Fenton; Femi Olatunbosun; John R Gordon; David Cotton
Journal:  J Clin Sleep Med       Date:  2013-04-15       Impact factor: 4.062

Review 2.  Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease?

Authors:  Michael A Grandner
Journal:  Int Rev Psychiatry       Date:  2014-04

3.  Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.

Authors:  Harun Karamanlı; Duygu Özol; K Serife Ugur; Zeki Yıldırım; Ferah Armutçu; Bulent Bozkurt; Ramazan Yigitoglu
Journal:  Sleep Breath       Date:  2012-09-04       Impact factor: 2.816

4.  Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy.

Authors:  Ye Wang; Richard B Meagher; Suresh Ambati; Ping Ma; Bradley G Phillips
Journal:  Sleep Breath       Date:  2020-10-09       Impact factor: 2.816

5.  Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography.

Authors:  Tiffany J Braley; Ronald D Chervin; Benjamin M Segal
Journal:  Mult Scler Int       Date:  2012-12-20

Review 6.  Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.

Authors:  Konstantinos Archontogeorgis; Evangelia Nena; Nikolaos Papanas; Paschalis Steiropoulos
Journal:  Pulm Med       Date:  2014-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.